Clinical Trials
18 trialsNCT04400695 2024-01-24
A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2
RemeGen Co., Ltd.
Phase 3 Unknown
NCT02465736 2024-01-16
Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)
Sun Yat-sen University
Phase 3 Unknown
NCT02448797 2021-07-20
EVIDENCE
Betta Pharmaceuticals Co., Ltd.
Phase 3 Unknown
NCT04665986 2020-12-14
Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer
Zhejiang Cancer Hospital
Phase 3 Unknown
NCT03402048 2020-11-04
EPIC
University of Turin, Italy
Phase 3 Unknown
NCT04307147 2020-03-13
NX in Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy
Fudan University
Phase 3 Unknown
NCT03656393 2018-09-04
RCTACSCNSCLC
Shenzhen People's Hospital
Phase 3 Unknown
NCT03359694 2017-12-02
Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 3 Unknown
NCT03006614 2017-01-16
PERS
Sun Yat-sen University
Phase 3 Unknown
NCT02579564 2016-10-21
Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients
Xinqiao Hospital of Chongqing
Phase 3 Unknown
NCT02281708 2014-11-03
Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung Adenocarcinoma
Seoul National University Hospital
Phase 3 Unknown
NCT00003447 2013-12-19
Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00003240 2013-12-18
Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00004100 2013-12-18
Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00379457 2013-08-12
Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01126138 2011-05-04
Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)
ChineseAMS
Phase 3 Unknown
NCT00430001 2008-05-09
Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast Cancer
Danish Breast Cancer Cooperative Group
Phase 3 Unknown
NCT00265694 2005-12-15
Random Trial for Elderly Patients With NSCLC
Inje University
Phase 3 Unknown